HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Granzyme B ELISPOT assay to measure influenza-specific cellular immunity.

Abstract
The immunogenicity and efficacy of influenza vaccination are markedly lower in the elderly. Granzyme B (GrzB), quantified in fresh cell lysates, has been suggested to be a marker of cytotoxic T lymphocyte (CTL) response and a predictor of influenza illness among vaccinated older individuals. We have developed an influenza-specific GrzB ELISPOT assay using cryopreserved PBMCs. This method was tested on 106 healthy older subjects (ages 50-74) at baseline (Day 0) and three additional time points post-vaccination (Day 3, Day 28, Day 75) with influenza A/H1N1-containing vaccine. No significant difference was seen in GrzB response between any of the time points, although influenza-specific GrzB response appears to be elevated at all post-vaccination time points. There was no correlation between GrzB response and hemagglutination inhibition (HAI) titers, indicating no relationship between the cytolytic activity and humoral antibody levels in this cohort. Additionally, a significant negative correlation between GrzB response and age was observed. These results reveal a reduction in influenza-specific GrzB response as one ages. In conclusion, we have developed and optimized an influenza-specific ELISPOT assay for use with frozen cells to quantify the CTL-specific serine protease GrzB, as a measure of cellular immunity after influenza vaccination.
AuthorsHannah M Salk, Iana H Haralambieva, Inna G Ovsyannikova, Krista M Goergen, Gregory A Poland
JournalJournal of immunological methods (J Immunol Methods) Vol. 398-399 Pg. 44-50 (Dec 15 2013) ISSN: 1872-7905 [Electronic] Netherlands
PMID24055591 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2013.
Chemical References
  • Influenza Vaccines
  • GZMB protein, human
  • Granzymes
Topics
  • Age Factors
  • Aged
  • Enzyme-Linked Immunospot Assay (methods)
  • Female
  • Granzymes (blood, immunology)
  • Humans
  • Immunity, Cellular (drug effects)
  • Influenza A virus (immunology, metabolism)
  • Influenza Vaccines (administration & dosage, immunology)
  • Influenza, Human
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: